The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yawn yawn......
Wow you are boring! Goodbye!!! p.s NCYT went up over 1000% if Native Antigen are even a small part of the coronavirus solution then yes they could be worth serious money! But you know that so I dont know why you are arguing.........
Oh, the billion pound company ?
Dream on !
You are obviously a disgruntled angry fellow! But I am not interested in arguing with you so Adios!!!
Again read below I am not interested in what you are spouting on about Barchid! I am here because I like what I see in Native Antigen and its huge potential going forward in the ongoing Coronavirus crisis. MERC simply gives me exposure to that.
Solstace
Why do you repeat this?
We can see that Feb RNS was a stock shuffling "tax planning" manouevre, resulting in no effective change except within the family, I emphasised that in my correction to your post.
What part of that very clear rns do you not understand ?
What about the ratherl miserly holdings of the other directors, why no comment on that?
DYOR
Anyway cheers for all that, but im not overly interested in all of Mercias assets just the bio tech in particular Native Antigen and the current global pandemic
RNS 4th Feb 20
In aggregate, the total number of Ordinary Shares in which Ray Chamberlain is interested remains unchanged, representing 14.73% of the Company's issued Ordinary Share capital.
Solstace
Inaccurate !
He held those shares and sold them into a vehicle for the benefit of his family & tax planning, he has owned them for years, I believe, probably from a sale of his company to Mercia.
Where is the CFO buying, or the Chair, other than options ?
If you do your research properly you will see that in the RNS of Dec 23rd the total number of shares held by directors was 73.169 mill of which 64.824 are/were held by Chamberlain, leaving a mere 8.345 mill held between another 6 directors (who actually own shares in Merc), which at the current bid price of 24.2p are worth £2mill.
So between the "gang of 6" their holdings are worth £336,000 each, on average, which HAVE NOT BEEN ADDED TO according to RNS since then.
Furthermore I believe, when you dyor, that they came from options anyway.
Are you honestly trying to convince us that they have real skin in the game?
Why did you not point this out when you were quoting the RNS to us all ?
Lots of director buys all the way up to a shade under 40pps
Are you referring to this? He holds 64,824,766
04-Feb-20 Buy Raymond Kenneth Chamberlain 26.60 GBX 6,149,752 64,824,766
Solstace
And MERC price is still dropping.
Don't you think that the BoD would be in buying now if this investment of theirs is going to transform Mercia ?
Our infectious disease reagents are widely adopted by pharmaceutical, in vitro diagnostics and vaccine manufacturers, as well as leading academic groups in cutting-edge research, where correct folding and glycosylation of proteins is vital. We also offer our expertise on a contract basis to other sectors where highly purified proteins are required.
https://thenativeantigencompany.com/
Private company but my guess would be we will hear more news from them quite soon!
About Us
Founded in 2010, The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Our portfolio of reagents continues to expand rapidly, and we are widely acknowledged to be a primary source of reagents and kits for the study of emerging diseases